Anemia, characterized by insufficient red blood cells for oxygen transport, is a common condition during pregnancy. The body's increased blood requirement for supporting fetal growth demands a higher intake of iron and folate, surpassing normal nutrient levels. While mild anemia is typical in pregnant women, its severity can escalate due to low iron or vitamin levels and other factors. The market for addressing anemia in pregnancy focuses on meeting nutritional needs and ensuring the well-being of both mother and baby.
According to Data Bridge Market Research, the Anemia in Pregnancy Market accounted for CAGR of anemia in the pregnancy market tends to be around 8.8% in the mentioned forecast period. The market was valued at USD 160.71 million in 2022 and would grow to USD 315.55 million by 2030.
“Increasing incidence of anemia”
The prevalence of anemia is significant in Australia and globally, affecting over 1.5 billion people worldwide. In Australia, anemia is particularly common among certain populations, with high rates observed in women, pre-school-aged children, and the elderly. Despite the burden of anemia, the market for treatments and interventions continues to grow. The increasing incidence of target diseases like rheumatoid arthritis, kidney conditions, autoimmune diseases, and others drives the demand for anemia-related products, fueling the market growth.
What restraints the growth of anemia in the pregnancy market?
“Side-effects of iron supplements”
The market growth of iron drugs may be hindered due to the occurrence of several side effects associated with their intake. Common digestive issues like nausea, stomach aches, loss of appetite, constipation, and vomiting are frequently reported. Moreover, higher doses of these drugs can lead to tiredness, weakness, rapid or shallow breathing, bluish skin, fatigue, convulsions, pale skin, or fingernails. These adverse effects pose obstacles to the market's expansion and adoption of iron drugs.
Segmentation: Anemia in Pregnancy Market
The anemia in pregnancy market is segmented on the basis of cause, treatment, route of administration, prescribing weeks, end user, and distribution channel.
- On the basis of cause, the anemia in pregnancy market is segmented into folic acid deficiency, iron deficiency, vitamin b12 deficiency, and others.
- On the basis of treatment, the anemia in pregnancy market is segmented into iron products, folic acid supplementation, and others.
- On the basis of route of administration, the anemia in pregnancy market is segmented into oral, intravenous, and intramuscular.
- On the basis of prescribing weeks, the anemia in pregnancy market is segmented into < 13 weeks, 13-27 weeks and ≥28 weeks.
- On the basis of end user, the anemia in pregnancy market is segmented into hospitals, specialty clinics, home healthcare, and others.
- On the basis of distribution channel the anemia in pregnancy market is segmented into hospital pharmacy, retail pharmacy, online pharmacy, and others.
To know more about the study visit, https://www.databridgemarketresearch.com/reports/australia-anemia-in-pregnancy-market
The Prominent Key Players Operating in the Anemia in Pregnancy Market Include:
- Viatris Inc. (U.S.)
- Aspen Pharmacare Australia Pty Ltd (Australia)
- PharmaCare Laboratories Australia (Australia)
- AFT Pharmaceuticals (New Zealand)
- Bayer AG (Germany)
- A Nelson & Co Ltd (U.K.)
- BLACKMORES (Australia)
- Care Pharma (India)
Above are the key players covered in the report, to know about more and exhaustive list of anemia in pregnancy market companies contact, https://www.databridgemarketresearch.com/contact
Research Methodology: Australia Anemia in Pregnancy Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
